Generics Bulletin is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Azithromycin Leads Off UK Rises In January

Pricewatch UK – January 2024

Executive Summary

Azithromycin topped our rundown of the steepest UK generic trade price rises in January 2024, based on figures from WaveData.

You may also be interested in...



Vardenafil Vaults To The Top Of UK Price Rises In March

Price increases from multiple suppliers pushed vardenafil to the top of our Biggest Risers table for March 2024.

Multiple UK Generics See Triple-Digit Rises In February

A raft of different generics saw their average UK trade price more than double in February 2024, according to the latest figures from market researcher WaveData.

Riluzole Prices Skyrocket As UK Shortages Bite

One of the sharpest UK generic price increases seen for years occurred in December, with riluzole 50mg tablets suddenly becoming more than 20 times more expensive than in the previous month, amid shortages of the motor neurone diseases treatment.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

GB153294

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel